How do you plan to get big drug companies on board with this new technology? Changing their workflows is going to be a massive undertaking!
This question is part of the following Ask The Expert session:
3D Bioprinting – Enabling Drug Discovery and Development and Cell Based Therapies
Answered by:
Job Title: Biomedical Automation Application Engineer
Answer
That is a great question! We will start small. Many companies have “innovation” groups, or automation teams. These are the people that are currently looking at bioprinting and bringing 3D cell culture into the drug discovery and development workflows. I am working with them to get the dispensing technology that works for their particular material and their particular specs. Once we know which type of dispenser will work, we can begin to augment their current automation framework and integrate our components. We’ve done this in both bioprinting R&D labs as well as highly automated production environments.
This post is sponsored by Izumi International, Inc..